Follow the BALAXI PHARMACEUTICALS LIMITED stock price and the full insider trade history of the company, a listed issuer based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, BALAXI PHARMACEUTICALS LIMITED has logged 15 public disclosures. Market capitalisation: €1.3bn. The latest transaction was reported on 12 April 2024 (Sale). Among the most active insiders: KUNAL MAHENDRA BHAKTA. All data is free.
15
Insider Decl.
n/a
Thresholds
€1m
9 ops.
Buy Volume
€789,566
6 ops.
Sell Volume
18Σ signal
Buys €1m€789,566 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,663 of 29,063 companies
29.7
score / 100
Value
25
Quality
35
FCF yld-36%
Earn yld1.1%
EV/EBITDA16.7x
ROE0.6%
Gross mgn44%
Net mgn0.5%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.